Loading clinical trials...
Loading clinical trials...
In this study, consecutive 600 patients with LAGC(cT2-4NanyM0) who underwent NACT between Jan. 2010 and Jun. 2022 were identified from two tertiary hospitals. The mCXI was constructed based on Random ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fujian Medical University
NCT07660627 · Esophageal Adenocarcinoma, Gastric Cancer, and more
NCT07432633 · Colorectal Cancer, Epithelial Ovarian Cancer, and more
NCT06764875 · HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
NCT07431281 · Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, and more
NCT05872295 · Breast Cancer, Gastric Cancer, and more
Fujian Medical University Union Hospital
Fuzhou, Fujian
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions